Fundraising Fox
/Companies
Sign in

Commit Biologics

Aarhus, DK · Founded 2021 · 32 employees on LinkedIn · 3 known investors

Find your way into Commit Biologics

Sign up to see every warm intro you have to Commit Biologics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Commit Biologics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Commit Biologics develops a complement-targeted drug discovery platform and antibody-based therapeutics for oncology, autoimmune diseases, and infectious disease indications. The company combines structural biology and complement research to advance novel therapeutic programs.

BiotechHealthtechMedical Devices

Founders & leadership

Commit Biologics was founded in 2021 by Dennis, Nick, Mikael, and Heidi.

D
DennisCOO & Co-founder
N
NickHead of Discovery & Co-founder
M
MikaelHead of Platform Technology & Co-founder
H
HeidiHead of Drug Screening & Co-founder
T
ThomasCEO

Investors · 3

Bioqube VenturesreportedBrussels · $108K – $6.5M

How we know: funding news · Not right? Tell us

Novo HoldingsreportedHellerup · $1.1M – $54M

How we know: funding news · Not right? Tell us

Funding

SEC filings, press & company announcements
  • Undisclosed amountextension to Seed FinancingJan 2025
    Source ↗
  • Undisclosed amountseed financingMay 2024 · 2 sources
    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Commit Biologics Raises €16M in Seed Financingfinsmes.com · May 2024Commit Biologics launches with €16m seed financing to pioneer complement system activation to treat cancer and autoimmune disease — Commit Biologicscommitbio.com · May 2024

Frequently asked questions

What does Commit Biologics do?
Commit Biologics develops a complement-targeted drug discovery platform and antibody-based therapeutics for oncology, autoimmune diseases, and infectious disease indications. The company combines structural biology and complement research to advance novel therapeutic programs.
Who founded Commit Biologics?
Commit Biologics was founded by Dennis, Nick, Mikael, Heidi in 2021.
Who are Commit Biologics's investors?
Commit Biologics's investors include Korys, Bioqube Ventures, Novo Holdings.
Where is Commit Biologics headquartered?
Commit Biologics is headquartered in Aarhus, DK.